We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Light-Enhanced Microneedle Vaccine Prevents Melanoma Development

By LabMedica International staff writers
Posted on 20 Nov 2017
Print article
Image: Melanin protein (light refracting granular material at the center of the photomicrograph) in a pigmented melanoma (Photo courtesy of Wikimedia Commons).
Image: Melanin protein (light refracting granular material at the center of the photomicrograph) in a pigmented melanoma (Photo courtesy of Wikimedia Commons).
A novel immunotherapeutic vaccine prevented the development of skin cancer in a mouse model by exploiting the ability of the protein melanin to transform light energy into heat.

Melanin is capable of transforming 99.9% of the absorbed sunlight energy into heat, which reduces the risk of skin cancer. In order to exploit this property, investigators at the University of North Carolina (Chapel Hill, USA) developed a melanin-mediated cancer immunotherapy strategy using a transdermal microneedle patch. A whole cell lysate prepared from cells of the B16F10 melanoma was augmented with melanin, and this mixture was loaded into polymeric microneedles that allowed sustained release of the lysate upon insertion into the skin.

The investigators used near-infrared light (IR) irradiation to induce the melanin in the patch to generate heat, which promoted tumor-antigen uptake by dendritic cells, and led to enhanced antitumor vaccination.

In a paper published in the November 10, 2017, online edition of the journal Science Immunology, the investigators reported that they divided a population of mice into three groups: one group was treated with the patch and was exposed to IR light; one group was treated with the patch, but was not exposed to IR light; and one group was treated with a patch that did not contain the cell lysate-melanin mixture. Ten days after initiation of the patch treatment, the mice were injected with active melanoma cells. Within one month, all of the mice that had received the empty patch died from melanoma. The lysate patch without exposure to near IR light was only slightly protective and only 13% of the mice survived. In contrast, 100% of the mice that had been treated with the active lysate patch and IR light survived after two months, and no tumors were detected in 87% of the animals. The enhanced results generated by exposure to IR light was attributed to local heating that caused formation of a fever-like environment in the skin, which promoted release of lysate from the microneedles, effectively attracting and activating immune cells.

"Melanin is a natural pigment that can efficiently transform absorbed sunlight energy into heat," said senior author Dr. Zhen Gu, professor of medicine at the University of North Carolina. "We demonstrated that melanin, which is found at high levels in melanoma, can actually be used to help treat melanoma. We do this by shining near infrared (IR) light on a therapeutic skin patch, which promotes the systemic immune response that fights cancer. These results are encouraging, but we are in the early stages of development. The next step would be a large animal study to further evaluate the safety and efficacy of the technique. And while it is much too early to estimate cost, we think that the treatment could be scaled up and would be affordable."

Related Links:
University of North Carolina

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Researchers have found a way to spot the debilitating disease Alzheimer\'s before it develops into dementia (Photo courtesy of 123RF)

Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia

Alzheimer’s disease is well known for its slow development over many years, which typically leads to treatment interventions only after the disease has advanced to stages where it may be nearly impossible... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more